Ken Griffin Oric Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 7,800 shares of ORIC stock, worth $63,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,800

Holding current value

$63,726

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.52 - $11.9 $43,367 - $68,627	5,767 New	5,767 $59,000
Q3 2023 Nov 14, 2023	BUY	$6.05 - $9.28 $403,728 - $619,272	66,732 Added 85.25%	145,007 $877,000
Q2 2023 Aug 14, 2023	SELL	$4.95 - $8.4 $204,573 - $347,155	-41,328 Reduced 34.55%	78,275 $607,000
Q1 2023 May 15, 2023	BUY	$4.26 - $6.75 $174,532 - $276,547	40,970 Added 52.1%	119,603 $681,000
Q4 2022 Feb 14, 2023	BUY	$2.41 - $5.89 $159,532 - $389,894	66,196 Added 532.25%	78,633 $463,000
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $592,042 - $984,858	-187,950 Reduced 93.79%	12,437 $40,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.07 $81,810 - $214,221	-30,300 Reduced 13.13%	200,387 $898,000
Q1 2022 May 16, 2022	BUY	$4.54 - $16.1 $977,507 - $3.47 Million	215,310 Added 1400.21%	230,687 $1.23 Million
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $62,614 - $99,316	-3,938 Reduced 20.39%	15,377 $322,000
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $335,501 - $489,442	19,315 New	19,315 $341,000
Q1 2021 May 17, 2021	SELL	$23.67 - $36.85 $957,096 - $1.49 Million	-40,435 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$20.32 - $39.8 $544,007 - $1.07 Million	-26,772 Reduced 39.84%	40,435 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$19.5 - $31.26 $1.18 Million - $1.89 Million	60,376 Added 883.85%	67,207 $1.68 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $175,420 - $260,397	6,831 New	6,831 $230,000

Others Institutions Holding ORIC

# of Institutions

124

Shares Held

66.6M

Call Options Held

7.8K

Put Options Held

700

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $323M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account